Article info

Download PDFPDF

Original research
Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry

Authors

  1. Correspondence to Dr Stefan Braune; sbraune{at}neurotransdata.com
View Full Text

Citation

Braune S, Rossnagel F, Dikow H, et al
Impact of drug diversity on treatment effectiveness in relapsing-remitting multiple sclerosis (RRMS) in Germany between 2010 and 2018: real-world data from the German NeuroTransData multiple sclerosis registry

Publication history

  • Received January 7, 2021
  • Accepted July 17, 2021
  • First published August 3, 2021.
Online issue publication 
August 03, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.